News

Palisade Bio to Present Groundbreaking Research at DDW 2025

Palisade Bio to Present Groundbreaking Research at DDW 2025

Palisade Bio to Showcase Innovative Research at DDW 2025

Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company dedicated to enhancing treatment options for autoimmune and inflammatory diseases, is set to present its groundbreaking research at the reputable Digestive Disease Week (DDW) 2025. This premier event, gathering experts in gastroenterology, will take place in early May.

Highlighting PALI-2108's Potential

Palisade Bio’s lead project, PALI-2108, a colon-specific PDE4 inhibitor prodrug, is generating interest within the scientific community. The company has received special recognition for its exciting research, which will be highlighted during poster presentations at the conference. Notably, one abstract from Palisade Bio was ranked in the top 10% of all submissions to the American Gastroenterological Association (AGA). This accomplishment reflects the significance of their findings in the realm of gastroenterology.

Details of the Poster Presentations

During DDW 2025, Palisade Bio will participate in two essential poster presentations showcasing the efficacy and potential of PALI-2108:

  • Poster Presentation: The session titled "Transcriptional, Epigenetic and Genetic Regulation of GI Function and Disease" will occur on May 4, featuring the title "A Bioinformatic Approach to PALI-2108 Treatment in Ulcerative Colitis Reveals the Potential for Anti-Fibrotic Efficacy with Local PDE4 Inhibition in Intestinal Fibrosis." This research explores the promising anti-fibrotic effects of PALI-2108.
  • DDW Poster of Distinction: On May 5, Palisade Bio will present in the "In Vivo Models of Gastrointestinal Disorders" session. The title "PALI-2108, a Colon-Specific PDE4 Inhibitor Prodrug, Is Bioactivated in the Colon and Reduces Colon Tissue PDE4B in a Dose-Dependent Manner, Increasing cAMP and Suppressing TNF-? in a Mouse Model of Colitis" showcases the prodrug's significant effects.

The Significance of Digestive Disease Week

DDW is recognized globally as a leading forum for professionals in gastroenterology. It serves as an ideal platform for leading researchers, clinicians, and pharmaceutical industry leaders to share insights and advancements in the treatment of digestive diseases. The notable presence of Palisade Bio highlights the company’s commitment to making strides in this important field of medicine.

About Palisade Bio

Palisade Bio focuses on creating innovative therapeutics with a targeted approach aimed at improving the lives of patients suffering from autoimmune, inflammatory, and fibrotic diseases. Their strategic research endeavors are designed to revolutionize therapeutic treatments and bolster the healthcare landscape. As the company progresses, it aspires to make significant changes in the treatment of chronic conditions that affect many individuals.

Conclusion

The forthcoming presentations at DDW 2025 mark a significant milestone for Palisade Bio as they continue to advance their research and development efforts. The company is poised to influence the future of treatments for ulcerative colitis and related inflammatory disorders, and the outcomes from these sessions may play a crucial role in their path forward.

Frequently Asked Questions

What is DDW?

Digestive Disease Week (DDW) is a premier event that convenes experts in gastroenterology to discuss the latest research and innovative treatments.

What is PALI-2108?

PALI-2108 is a colon-specific PDE4 inhibitor prodrug developed by Palisade Bio aimed at treating ulcerative colitis and other fibrotic conditions.

How is PALI-2108 being recognized at DDW 2025?

Palisade Bio's research on PALI-2108 has received special recognition, with one of its abstracts selected as a Poster of Distinction.

What are the potential benefits of PALI-2108?

PALI-2108 has shown promise in improving treatment outcomes for patients with ulcerative colitis, particularly through anti-fibrotic efficacy.

How can I learn more about Palisade Bio?

You can visit their official website, www.palisadebio.com, for detailed information on their research, products, and developments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FSS Unveils AI Tool to Simplify Bankruptcy Cases

Updated Category News Views 0

AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....

Continue Reading
OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Updated Category News Views 0

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

Continue Reading
Roof Replacement Timelines: Key Insights for PA Homeowners

Updated Category News Views 0

There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...

Continue Reading
EPR Fireworks, Schedule2.IT Enhance EMS Integration

Updated Category News Views 0

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Continue Reading
JennAir and Cosentino Introduce Seamless Kitchen Aesthetics

Updated Category News Views 0

It's not every day that the kitchen landscape gets a bold makeover, but JennAir and Cosentino seem to think it's time. Introducing their latest splash, the JennAir x Dekton panel collection is here to redefine what luxury kitchens can look like—an embodiment of seamless beauty that’s more sculpture than cooking space. Elevating Kitchen Design So, what's the buzz about...

Continue Reading
Crucial Insights for South GA Home Insurance Choices

Updated Category News Views 0

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

Continue Reading
Vortex Expands UK Reach with Torrent Acquisition Boost

Updated Category News Views 0

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

Continue Reading
Local Expertise in Real Estate: Key to Success?

Updated Category News Views 0

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...

Continue Reading
University of Phoenix Grads Shine in Job Readiness

Updated Category News Views 0

University of Phoenix Graduates Proving Their Worth Dive straight into the world of University of Phoenix grads, and you're looking at some folks who seem to have the workplace game figured out. A fresh Harris Poll, done on behalf of the University itself, paints a rosy picture of these graduates from the eyes of those who actually supervise them. Turns out, managers are...

Continue Reading
Superga and Pasqua's Unlikely Fashion-Vineyard Fusion

Updated Category News Views 0

Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...

Continue Reading

Top 5 Most Recently Viewed Articles

SpartanNash Foundation Hits Landmark Donation Milestone

Updated Category News Views 77

SpartanNash Foundation Achieves Record Donation for Local Food Pantries Shoppers have joined together with the SpartanNash Foundation to make a significant impact this holiday season, donating an incredible $780,000, which translates into approximately 285,000 meals. This exemplary act of community spirit showcases the power of collective efforts aimed at fighting food...

Continue Reading
ANOME Introduces AnoMEME: Revolutionizing Meme Tokens

Updated Category News Views 165

AnoMEME: The Future of Meme Tokens In the vibrant and ever-evolving world of cryptocurrency, innovation drives success, and ANOME is at the forefront of this evolution. Their latest announcement about the launch of AnoMEME presents a groundbreaking approach to meme tokens—transforming them into what they call 'Meme Cards' within their ecosystem. This initiative marks a...

Continue Reading
Advanced Flower Capital Inc. Delivers Impressive Q3 Results

Updated Category News Views 77

Financial Highlights of Advanced Flower Capital Inc. Advanced Flower Capital Inc. has reported an impressive financial performance for its third quarter of 2024. The company, previously known as AFC Gamma, Inc., achieved a GAAP net income of $1.4 million, translating to $0.06 per basic weighted average common share. Additionally, the reported Distributable Earnings...

Continue Reading
Dreyfus High Yield Strategies Fund Achieves New 52-Week Peak

Updated Category News Views 52

Rally of the Dreyfus High Yield Strategies Fund The Dreyfus High Yield Strategies Fund (DHF) has just pulled off quite the feat—soaring to a staggering 52-week high at $2.63. This dramatic climb isn't just for show; it embodies an uptick in investor trust and shows how well the fund’s strategy aligns with market realities. With an eye-popping annual growth of nearly...

Continue Reading
Exploring Growth in the Biologics Contract Development Market

Updated Category News Views 123

Understanding the Growth of the Biologics CDMO Market The Biologics Contract Development and Manufacturing Organization (CDMO) market is on an exciting growth trajectory, estimated to grow significantly due to the increasing demand for biologics, biosimilars, and advanced therapies. With a projected growth of USD 10.63 billion from 2024 to 2028, this sector is anticipated...

Continue Reading